Manufacturing of RNA vaccines & therapeutics
As an RNA vaccine and drug CDMO company, we deliver GMP RNA and GMP mRNA in a quality required for RNA based vaccines and treatments
To circumvent chemical synthesis limitation
With polyA tail and cap
Used for gene editing technique like CRISPR/Cas9, TALEN or ZFNs
Sequence lengths from
700 to 6000 nucleotides already tested
30 mL to 40L production scale
10 to 20g GMP manufacturing scale
Our RNA services cover the process development, GMP plasmid production, plasmid linearization
and GMP manufacturing of IVT-RNA API for use in Tox studies and Human clinical trials.
Quality Management System
Our Quality Management System ensures that every employee operates within the guidelines to produce and deliver GMP RNA drug substance in accordance with ICH Q7.
Each RNA production batch intended to be used in human clinical trials is produced in our GMP facilities accredited by the Belgian ministry of health.
Note: The non-infringement of any patents covering the operation of any process or the use of the product alone or in combination with other for use or sale of the products mentioned above is not warranted by Eurogentec. The customer has the sole responsibility of all and any use of Eurogentec’s products.